Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ +O3ze
L
=If % m9
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© :N^1T6v
+V1EqC*
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© 8rXq-V_u
C.
s{&
1.Co-stimulators (or co-stimulating molecules) wNDLN`,^H
aGNVqS%y
2.NK-kB /7*jH2
F1R91V|
3.Immunoglobulin superfamily 2.}<VivT
QRdNi1&M
4.antigen-presenting cell (APC) !^!<Xz
;
>1a-}>r
5.death domain $/],QD_;"
4C[,S|J
6.CCR and CXCR UA{sUj+?
!$AVlMnJ
7.Lectin (or mitogen) \^;Gv%E
]l+Bg;F#V
8.Clusters of differentiation, CD) NmST1pMk
Y_>z"T
9.B7 family 51.F,uY
riZFcVsB
10.Cytotoxic T lymphocyte, CTL) 52m^jT Sx
qh0)~JL4
11.IL-15 and IL-15 receptor (IL-15R) )&+_T+\
nen6!bw4
12.MHC restriction %
2BFbaE
N ED`GU
13.Affinity-chromatography I.R3?+tZ
^K@r!)We
14.Cyctosprin A, CsA vc6UA%/f
?*}76u
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) \*LMc69
|rdG+>
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© Lj *FKP\{
KblOP{I
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 ><LIOFqsS
)FWF T:P~
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ qqw6p j
ZhxMA*fL
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ UgJlXB|a%2
ejgg.G ^
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© kUP[&/Lc
[2i+f<
ÃâÒßѧרҵ£º G8u8&|
YD.3FTNGC
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ x ?^c:`.
^{6Y7T]
Ïû»¯ÄÚ¿Æ£º 0
p2 0Rt
{)b`fq
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ OzO_E8Kb\
d[~c-G6
ѪҺ²¡Ñ§×¨Òµ£º E*(Q'p9C
K"}Dbr
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿